Press Release: BrainStorm : BrainStorm Cell Therapeutics Announces Full Year 2024 Financial Results and Provides Corporate Update
/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...
Read full article »
Brainstorm is a New York-based biotechnology company that researches and develops stem cell therapies for the treatment of neurodegenerative diseases.
Read more